Current Neuro-Oncology

Volume 21 Number 2
February 2019


Home > Publications > Current Neuro-Oncology > Volume 21, Year 2019 > Number 2, February



CONTENTS


CENTRAL NERVOUS SYSTEM TUMORS

GLIOMAS
BRAIN STEM GLIOMAS
HIGH-GRADE GLIOMAS
LOW-GRADE GLIOMAS

DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS
GLIOBLASTOMA
OLIGODENDROGLIOMAS
OLIGODENDROGLIOMA

METASTATIC TUMORS

NEUROFIBROMATOSIS





CENTRAL NERVOUS SYSTEM TUMORS

.

Jussila MP, Remes T, Anttonen J, Harila-Saari A, Niinimäki J, Pokka T, Koskenkorva P, Sutela A, Toiviainen-Salo S, Arikoski P, Riikonen P, Arola M, Lähteenmäki P, Sirkiä K, Rantala H, Suo-Palosaari M, Ojaniemi M.
Late vertebral side effects in long-term survivors of irradiated childhood brain tumor.
PLoS One. 2018 Dec 18;13(12):e0209193. doi: 10.1371/journal.pone.0209193. eCollection 2018.
Source | Full text | Similar articles



.

Karipidis K, Elwood M, Benke G, Sanagou M, Tjong L, Croft RJ.
Mobile phone use and incidence of brain tumour histological types, grading or anatomical location: a population-based ecological study.
BMJ Open. 2018 Dec 9;8(12):e024489. doi: 10.1136/bmjopen-2018-024489. Correction
Source | Full text | Similar articles | Correction



GLIOMAS

.

Jhaveri J, Cheng E, Tian S, Buchwald Z, Chowdhary M, Liu Y, Gillespie TW, Olson JJ, Diaz AZ, Voloschin A, Eaton BR, Crocker IR, McDonald MW, Curran WJ, Patel KR.
Proton vs. Photon Radiation Therapy for Primary Gliomas: An Analysis of the National Cancer Data Base.
Front Oncol. 2018 Nov 28;8:440. doi: 10.3389/fonc.2018.00440. eCollection 2018.
Source | Full text | Similar articles



.

Karlsson I, Veevnik D, Fedulov A, Yurkshtovich N, Yurkshtovich T, Pejler G, Lokot I.
Local delivery of temozolomide via a biologically inert carrier (Temodex) prolongs survival of glioma patients irrespectively of the MGMT methylation status.
Neoplasma. 2018 Dec 12. pii: 180613N393. doi: 10.4149/neo_2018_180613N393. [Epub ahead of print]
Source | Full text | Similar articles



.

Long S, Li M, Ou S, Li G.
The effect of marital status on glioma patient survival: analysis of 617 cases: A SEER-based study.
Medicine (Baltimore). 2018 Dec;97(52):e13900. doi: 10.1097/MD.0000000000013900.
Source | Full text | Similar articles



.

Navarria P, Minniti G, Clerici E, Tomatis S, Pinzi V, Ciammella P, Galaverni M, Amelio D, Scartoni D, Scoccianti S, Krengli M, Masini L, Draghini L, Maranzano E, Borzillo V, Muto P, Ferrarese F, Fariselli L, Livi L, Pasqualetti F, Fiorentino A, Alongi F, di Monale MB, Magrini S, Scorsetti M.
Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO).
J Neurooncol. 2018 Dec 4. doi: 10.1007/s11060-018-03059-x. [Epub ahead of print]
Source | Full text | Similar articles



BRAIN STEM GLIOMAS


.

Dawes W, Marcus HJ, Tisdall M, Aquilina K.
Robot-assisted stereotactic brainstem biopsy in children: prospective cohort study.
J Robot Surg. 2018 Dec 6. doi: 10.1007/s11701-018-0899-x. [Epub ahead of print]
Source | Full text | Similar articles



HIGH-GRADE GLIOMAS


.

Ene CI, Macomber MW, Barber JK, Ferreira MJ, Ellenbogen RG, Holland EC, Rockhill JK, Silbergeld DL, Halasz LM.
Patterns of Failure After Stereotactic Radiosurgery for Recurrent High-Grade Glioma: A Single Institution Experience of 10 Years.
Neurosurgery. 2018 Dec 20. doi: 10.1093/neuros/nyy520. [Epub ahead of print]
Source | Full text | Similar articles



.

Ge X, Xue X, Liu H, Wang Y, Xiao Z, Tian L, Chang X, Lin Q, Yu J.
Treatment of high-grade gliomas using escalating doses of hypofractionated simultaneous integrated boost-intensity-modulated radiation therapy in combination with temozolomide: A modified Phase I clinical trial.
J Cancer Res Ther. 2018;14(7):1482-1491. doi: 10.4103/jcrt.JCRT_51_18. Date of Web Publication: 19-Dec-2018
Source | Full text | Similar articles



LOW-GRADE GLIOMAS


.

Diaz-Aguilar D, ReFaey K, Clifton W, Durcanova B, Chen SG, Deen HG, Bydon M, Trifiletti DM, Pichelmann MA, Quiñones-Hinojosa A.
Prognostic factors and survival in low grade gliomas of the spinal cord: A population-based analysis from 2006 to 2012.
J Clin Neurosci. 2018 Dec 5. pii: S0967-5868(18)31244-X. doi: 10.1016/j.jocn.2018.11.025. [Epub ahead of print]
Source | Full text | Similar articles



.

Zhukova N, Rajagopal R, Lam A, Coleman L, Shipman P, Walwyn T, Williams M, Sullivan M, Campbell M, Bhatia K, Gottardo NG, Hansford JR.
Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma.
Cancer Med. 2019 Jan;8(1):40-50. doi: 10.1002/cam4.1799. Epub 2018 Dec 19.
Source | Full text | Similar articles



DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS



GLIOBLASTOMA


.

Alkhaibary A, Alassiri AH, AlSufiani F, Alharbi MA.
Ki-67 labeling index in glioblastoma; does it really matter?
Hematol Oncol Stem Cell Ther. 2018 Dec 8. pii: S1658-3876(18)30115-8. doi: 10.1016/j.hemonc.2018.11.001. [Epub ahead of print]
Source | Full text | Similar articles



.

Chang KT, Lin YY, Lin YY, Lin YL, Cheng H, Chang Y, Huang MC.
In Vivo Real-Time Discrimination Among Glioma, Infiltration Zone, and Normal Brain Tissue via Autofluorescence Technology.
World Neurosurg. 2018 Nov 1. pii: S1878-8750(18)32442-2. doi: 10.1016/j.wneu.2018.10.144. [Epub ahead of print]
Source | Full text | Similar articles



.

Dührsen L, Sauvigny T, Ricklefs FL, Mende KC, Schaper M, Matschke J, Goebell E, Westphal M, Martens T.
Seizures as presenting symptom in patients with glioblastoma.
Epilepsia. 2019 Jan;60(1):149-154. doi: 10.1111/epi.14615. Epub 2018 Dec 9.
Source | Full text | Similar articles



.

Fabbro-Peray P, Zouaoui S, Darlix A, Fabbro M, Pallud J, Rigau V, Mathieu-Daude H, Bessaoud F, Bauchet F, Riondel A, Sorbets E, Charissoux M, Amelot A, Mandonnet E, Figarella-Branger D, Duffau H, Tretarre B, Taillandier L, Bauchet L.
Association of patterns of care, prognostic factors, and use of radiotherapy-temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study.
J Neurooncol. 2018 Dec 6. doi: 10.1007/s11060-018-03065-z. [Epub ahead of print]
Source | Full text | Similar articles



.

Guseynova K, Liscak R, Simonova G, Novotny J Jr.
Gamma knife radiosurgery for local recurrence of glioblastoma.
Neuro Endocrinol Lett. 2018 Oct;39(4):281-287. Electronic/Online ISSN: 2354-4716.
Source | Full text | Similar articles



.

Hesari A, Rezaei M, Rezaei M, Dashtiahangar M, Fathi M, Rad JG, Momeni F, Avan A, Ghasemi F.
Effect of curcumin on glioblastoma cells.
J Cell Physiol. 2018 Dec 26. doi: 10.1002/jcp.27933. [Epub ahead of print]
Source | Full text | Similar articles



.

Hilf N, Kuttruff-Coqui S, Frenzel K, Bukur V, Stevanović S, Gouttefangeas C, Platten M, Tabatabai G, Dutoit V, van der Burg SH, Thor Straten P, Martínez-Ricarte F, Ponsati B, Okada H, Lassen U, Admon A, Ottensmeier CH, Ulges A, Kreiter S, von Deimling A, Skardelly M, Migliorini D, Kroep JR, Idorn M, Rodon J, Piró J, Poulsen HS, Shraibman B, McCann K, Mendrzyk R, Löwer M, Stieglbauer M, Britten CM, Capper D, Welters MJP, Sahuquillo J, Kiesel K, Derhovanessian E, Rusch E, Bunse L, Song C, Heesch S, Wagner C, Kemmer-Brück A, Ludwig J, Castle JC, Schoor O, Tadmor AD, Green E, Fritsche J, Meyer M, Pawlowski N, Dorner S, Hoffgaard F, Rössler B, Maurer D, Weinschenk T, Reinhardt C, Huber C, Rammensee HG, Singh-Jasuja H, Sahin U, Dietrich PY, Wick W.
Actively personalized vaccination trial for newly diagnosed glioblastoma.
Nature. 2019 Jan;565(7738):240-245. doi: 10.1038/s41586-018-0810-y. Epub 2018 Dec 19.
Source | Full text | Similar articles



.

Hou BL, Wen S, Katsevman GA, Liu H, Urhie O, Turner RC, Carpenter J, Bhatia S.
Magnetic Resonance Imaging Parameters and Their Impact on Survival of Patients with Glioblastoma: Tumor Perfusion Predicts Survival.
World Neurosurg. 2018 Dec 27. pii: S1878-8750(18)32908-5. doi: 10.1016/j.wneu.2018.12.085. [Epub ahead of print]
Source | Full text | Similar articles



.

Keskin DB, Anandappa AJ, Sun J, Tirosh I, Mathewson ND, Li S, Oliveira G, Giobbie-Hurder A, Felt K, Gjini E, Shukla SA, Hu Z, Li L, Le PM, Allesøe RL, Richman AR, Kowalczyk MS, Abdelrahman S, Geduldig JE, Charbonneau S, Pelton K, Iorgulescu JB, Elagina L, Zhang W, Olive O, McCluskey C, Olsen LR, Stevens J, Lane WJ, Salazar AM, Daley H, Wen PY, Chiocca EA, Harden M, Lennon NJ, Gabriel S, Getz G, Lander ES, Regev A, Ritz J, Neuberg D, Rodig SJ, Ligon KL, Suvà ML, Wucherpfennig KW, Hacohen N, Fritsch EF, Livak KJ, Ott PA, Wu CJ, Reardon DA.
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial.
Nature. 2019 Jan;565(7738):234-239. doi: 10.1038/s41586-018-0792-9. Epub 2018 Dec 19.
Source | Full text | Similar articles



.

Lombardi G, De Salvo GL, Brandes AA, Eoli M, Rudà R, Faedi M, Lolli I, Pace A, Daniele B, Pasqualetti F, Rizzato S, Bellu L, Pambuku A, Farina M, Magni G, Indraccolo S, Gardiman MP, Soffietti R, Zagonel V.
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol. 2019 Jan;20(1):110-119. doi: 10.1016/S1470-2045(18)30675-2. Epub 2018 Dec 3.
Source | Full text | Similar articles



.

Petzold J, Severus E, Meyer S, Bauer M, Daubner D, Krex D, Juratli TA.
Glioblastoma multiforme presenting as postpartum depression: a case report.
J Med Case Rep. 2018 Dec 20;12(1):374. doi: 10.1186/s13256-018-1909-3.
Source | Full text | Similar articles



.

Stavrinou P, Kalyvas A, Grau S, Hamisch C, Galldiks N, Katsigiannis S, Kabbasch C, Timmer M, Goldbrunner R, Stranjalis G.
Survival effects of a strategy favoring second-line multimodal treatment compared to supportive care in glioblastoma patients at first progression.
J Neurosurg. 2018 Nov 1:1-6. doi: 10.3171/2018.7.JNS18228. [Epub ahead of print]
Source | Abstract | Similar articles



.

Toms SA, Kim CY, Nicholas G, Ram Z.
Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial.
J Neurooncol. 2019 Jan;141(2):467-473. doi: 10.1007/s11060-018-03057-z. Epub 2018 Dec 1.
Source | Full text | Similar articles



.

Zheng X, Liao Y, Wang J, Hu S, Rudramurthy GR, Swamy MK, Rohit KC, Wang Y.
The Antineuroinflammatory Effect of Simvastatin on Lipopolysaccharide Activated Microglial Cells.
Evid Based Complement Alternat Med. 2018 Nov 7;2018:9691085. doi: 10.1155/2018/9691085. eCollection 2018.
Source | Full text | Similar articles



.

Zschaeck S, Wust P, Graf R, Misch M, Onken J, Ghadjar P, Badakhshi H, Florange J, Budach V, Kaul D.
Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma.
Radiat Oncol. 2018 Dec 19;13(1):251. doi: 10.1186/s13014-018-1194-8.
Source | Full text | Similar articles



OLIGODENDROGLIOMAS


.

Geevar T, Pai R, Chacko G, Malepathi K, Patel B, John J, Chacko AG, Balakrishnan R, John S.
Molecular profile of tumors with oligodendroglial morphology: Clinical relevance.
Neurol India. 2018 Nov-Dec;66(6):1726-1731. doi: 10.4103/0028-3886.246275.
Source | Full text | Similar articles



OLIGODENDROGLIOMA


.

Iwadate Y, Matsutani T, Hara A, Hirono S, Ikegami S, Kobayashi M, Ito D, Kawauchi D, Horiguchi K, Tamiya A, Higuchi Y.
Eighty percent survival rate at 15 years for 1p/19q co-deleted oligodendroglioma treated with upfront chemotherapy irrespective of tumor grade.
J Neurooncol. 2019 Jan;141(1):205-211. doi: 10.1007/s11060-018-03027-5. Epub 2018 Dec 18.
Source | Full text | Similar articles



METASTATIC TUMORS

.

Matsuo S, Amano T, Kawauchi S, Nakamizo A.
Multiple brain metastases from pancreatic adenocarcinoma presenting with simultaneous intratumoral hemorrhages: A case report.
World Neurosurg. 2018 Dec 19. pii: S1878-8750(18)32859-6. doi: 10.1016/j.wneu.2018.12.036. [Epub ahead of print]
Source | Full text | Similar articles



NEUROFIBROMATOSIS

.

D'Angelo F, Ceccarelli M, Tala, Garofano L, Zhang J, Frattini V, Caruso FP, Lewis G, Alfaro KD, Bauchet L, Berzero G, Cachia D, Cangiano M, Capelle L, de Groot J, DiMeco F, Ducray F, Farah W, Finocchiaro G, Goutagny S, Kamiya-Matsuoka C, Lavarino C, Loiseau H, Lorgis V, Marras CE, McCutcheon I, Nam DH, Ronchi S, Saletti V, Seizeur R, Slopis J, Suñol M, Vandenbos F, Varlet P, Vidaud D, Watts C, Tabar V, Reuss DE, Kim SK, Meyronet D, Mokhtari K, Salvador H, Bhat KP, Eoli M, Sanson M, Lasorella A, Iavarone A.
The molecular landscape of glioma in patients with Neurofibromatosis 1.
Nat Med. 2019 Jan;25(1):176-187. doi: 10.1038/s41591-018-0263-8. Epub 2018 Dec 10.
Source | Full text | Similar articles



bottom